| (210) | Number of the EPO application | 16729483 |
| (220) | Filing date of the EPO application | 2016.06.08 |
| (80) | EPO patent specification publication (B) | EPB nr. 42/2024, 2024.10.16 |
| (110) | EPO patent number | 3310809 |
| (11) | Number of the document | MD 3310809 T2 |
| (21) | Number of the application | e 2018 0401 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | SHARMA Anant N., US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | Anti-cgrp antibody formulation |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/18 (2006.01.01); C07K 16/26 (2006.01.01); A61K 39/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2025.03.31 |
| (30) | Priority | 201562180905 P, 2015.06.17, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/036407, 2016.06.08 |
| (87) | International publication | WO 2016/205037, 2016.12.22 |